Tested Applications
| Positive IHC detected in | mouse testis tissue, human prostate cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | PC-3 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
24564-1-AP targets PCOTH in IHC, IF/ICC, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag20092 Product name: Recombinant human PCOTH protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 8-107 aa of BC142999 Sequence: GTSEEGNLLSTVSPTVKALFGKTRVSPIFPFSPRSPFQPLIPRTPGSPWGPVGPASPLGPGFPIGPMGPGKPVGPKGPMLPLGPSGPVGPTSPLFPFCP Predict reactive species |
| Full Name | prostate collagen triple helix |
| Calculated Molecular Weight | 107 aa, 11 kDa |
| GenBank Accession Number | BC142999 |
| Gene Symbol | PCOTH |
| Gene ID (NCBI) | 542767 |
| RRID | AB_2918084 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q58A44 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
PCOTH may be involved in growth and survival of prostate cancer cells through the TAF-Ibeta pathway.
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for PCOTH antibody 24564-1-AP | Download protocol |
| IHC protocol for PCOTH antibody 24564-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |









